Letters of Intent are now accepted year-round for biannual reviews in August and February, replacing the previous fixed fall deadlines. If you are affiliated with a non-profit organization focused on product-oriented research, you are now officially eligible to apply. Additionally, note that awarded funds will be distributed with roughly 50% provided upfront and the remainder tied to project milestones.
Funder: Crohn's and Colitis Foundation
Due Dates: August 2026 (Letter of Intent) | February 2026 (Letter of Intent, previous)
Funding Amounts: Up to $500,000 per project per year; typical duration is 12 months with potential for renewal if milestones are met.
Summary: Supports the development of innovative products to improve the lives of people with inflammatory bowel diseases (IBD).
Key Information: LOIs accepted year-round but reviewed biannually; full proposals by invitation only.